venBio Select Advisor »

Ocular Therapeutix shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Ocular Therapeutix (OCUL) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Ocular Therapeutix

Tip: Access up to 7 years of quarterly data

All positions including Ocular Therapeutix held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocular Therapeutix by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2024-03-31 $65M 7.1M 9.10

More positions owned by venBio Select Advisor

United Therapeutics Corp Common (UTHR)
Apellis Pharmaceuticals Common (APLS)
Ascendis Pharma Sponsored ADR (ASND)
Sarepta Therapeutics Common (SRPT)
Madrigal Pharmaceuticals Common (MDGL)
Argenx Se Sponsored ADR (ARGX)
Krystal Biotech Common (KRYS)
Spdr Series Trust - S&p Biotech Etf (XBI)
Biomarin Pharmaceutical Common (BMRN)
Amicus Therapeutics Common (FOLD)
Cerevel Therapeutics Hldng Common (CERE)
Viking Therapeutics Common (VKTX)
Arrowhead Pharmaceuticals Common (ARWR)
Xenon Pharmaceuticals Common (XENE)
Alpine Immune Sciences Common (ALPN)

View all positions for venBio Select Advisor

Top funds holding Ocular Therapeutix

Summer Road
VR Adviser
Deep Track Capital
BlackRock
Vanguard Group
venBio Select Advisor
Opaleye Management
Logos Global Management
Citadel Advisors
TCG Crossover Management
Perceptive Advisors
Longwood Capital Partners
Geode Capital Management
Octagon Capital Advisors
State Street Corporation

View all funds holding Ocular Therapeutix